Daiwa Capital Markets America’s Quest Diagnostics DGX Stock Holding History

Daiwa Capital Markets America’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$225K	Buy	+4,200	New	+$249K	﹤0.01%	614

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Daiwa Capital Markets America's DGX Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Quest Diagnostics (DGX) in Q4 2013: 4,200 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #614 among its holdings.

455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

Daiwa Capital Markets America held 4,200 shares of Quest Diagnostics worth $225K as of Q4 2013.
Quest Diagnostics was a new Daiwa Capital Markets America position in Q4 2013.
Quest Diagnostics made up ﹤0.01% of Daiwa Capital Markets America's portfolio in Q4 2013, its #614 holding.
455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.